A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage
2006 Conference Coverage

American Society of Hematology
December 9-12, 2006 - Orlando, Florida

San Antonio Breast Cancer Symposium
December 14-17, 2006 - San Antonio, Texas

American Society for Therapeutic Radiology and Oncology
November 5-9, 2006 - Philadelphia, Pennsylvania

Chemotherapy Foundation Symposium
November 8-11, 2006 - New York, New York

International Kidney Cancer Symposium
September 22-23, 2006 - Toronto, Canada

Multinational Association of Supportive Care
June 22-24, 2006 - Toronto, Canada

American Society of Clinical Oncology
June 2-6, 2006- Atlanta, Georgia

American Urological Association
May 20-25, 2006- Atlanta, Georgia

Oncology Nursing Society
May 4-7, 2006- Boston, Massachusets

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Related News Stories
More Evidence that Vitamin D Reduces Risk of Cancer in Women (6/11/2007)

Gemzar® Combined with Eloxatin® or Platinol® Improves Survival for Patients with Advanced Pancreatic Cancer (7/16/2006)

Avastin®/Tarceva® Effective Alternative to Chemotherapy in Recurrent Non-Small Cell Lung Cancer (7/10/2006)

Velcade® Plus Gemzar®/Paraplatin® Highly Active in Advanced NSCLC (7/10/2006)

Lapatinib Superior to Hormonal Therapy in Patients with Renal Cell Carcinoma Failing Initial Therapy (7/6/2006)

Xaliproden Reduces Neuropathy of FOLFOX 4 Regimen (7/6/2006)

Induction Chemotherapy with Taxotere® Preserves Larynx Function (7/5/2006)

Thalomid® Plus Dexamethasone Superior to Dexamethasone Alone for Treatment of Multiple Myeloma (7/5/2006)

Xeloda® and Eloxatin® May Replace 5-FU and Platinol® for Treatment of Esophagogastric Cancer (7/3/2006)

Addition of Thalomid® to Chemotherapy Improves Survival in Small Cell Lung Cancer (6/30/2006)

Addition of Revlimid® to Dexamethasone Improves Survival in Relapsed Multiple Myeloma (6/26/2006)

Eloxatin®-Based Chemotherapy Improves Time to Treatment Failure in Gastric Cancer (6/23/2006)

More ASCO 2006 News »
Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.